INS and type 2 diabetes mellitus: The results of this study suggest that the combination of SZ-A and Met with premixed insulin is a potential treatment option for patients with T2DM whose blood glucose levels cannot be adequately controlled by oral medications, and SZ-A combined with premixed insulin may be more suitable for Chinese patients who consume higher levels of carbohydrates.